Indian AI drug discovery agency will get $1M to concentrate on uncommon ailments
Peptris Applied sciences from Bangalore, India has acquired $1 million in pre-seed funding in a spherical led by Speciale Make investments.
In an announcement, the AI-driven drug discovery firm mentioned it is going to use its recent funds to develop its analysis scope to cowl uncommon ailments, including to its current work in most cancers and irritation.
Cipla raises stake in digital pharma options supplier GoApptiv
Indian pharmaceutical big Cipla has elevated its stake in GoApptiv by Rs 420 million ($5 million) to 22.99%.
It has additional invested within the firm, which develops end-to-end digital options for pharmaceutical companies, as a part of its efforts to penetrate underserved communities throughout India and help improve entry to medicines.
Canadian insurtech Lydia AI targets South Korea
Lydia AI, a Canada-based medical insurance AI firm, has not too long ago signed expertise integration partnerships in South Korea.
It has formalised its ongoing collaboration with Hecto Knowledge; they’re piloting a sensible knowledge ecosystem inside insurer Metlife Korea’s 360Health software.
The Canadian insurtech has additionally entered into a brand new partnership with Tobecon to combine its predictive AI functionality into insurance coverage software program.
Ubie to launch Android model of AI symptom checker app within the US
Japanese startup Ubie is getting ready to launch the Android model of its AI-enabled symptom checker app in the US.
The cellular symptom checker, whose AI functionality was not too long ago recognised at Google Play’s Better of 2023 Awards, helps customers in figuring out their signs and connects them with the appropriate healthcare supplier. It’s now used over 100 million occasions since 2020; since launching within the US final yr, it has greater than two million makes use of thus far.
